Standalone Unaudited Financial Results For The Quarter Ended June 30, 2025
Awaiting price reaction for this filing.
Dolphin Medical Services reported Q1 FY26 (ended June 30, 2025) revenue from operations of Rs. 16.86 lakhs, up from Rs. 14.05 lakhs in Q1 FY25, a growth of nearly 20% year-on-year. Total income stood at Rs. 17.78 lakhs. The company swung to a net profit of Rs. 3.13 lakhs versus Rs. 1.03 lakhs in the same quarter last year, and compared to a loss of Rs. 7.00 lakhs in the preceding Q4 FY25. Basic EPS came in at Rs. 0.02 (vs Rs. 0.01 YoY). However, reserves remain deeply negative at Rs. (506.04) lakhs, reflecting accumulated historical losses. The Limited Review Report from Kota and Associates was clean, with no qualifications.
A modest return to profitability on a very small revenue base is positive, but the deeply negative reserves and tiny scale mean this is unlikely to materially move the stock. Investors should watch whether the profit trend sustains in coming quarters.